Bilateral endogenous endophthalmitis after holmium laser lithotripsy.
Endogenous endophthalmitis is a potentially blinding condition that occurs after the spread of organisms to the eye from a focus of infection elsewhere in the body. The holmium laser has gained increasing acceptance as being safe and effective for endoscopic lithotripsy. We report what we believe to be the first time endogenous endophthalmitis has been described as occurring after holmium laser lithotripsy, although it has been reported after extracorporeal shock wave lithotripsy. This 55-year-old woman developed infections in both eyes 2 to 3 weeks after the lithotripsy, with a good response to appropriate antibiotic treatment.
Hu
Victor
V
Birmingham and Midland Eye Institute, City Hospital, Dudley Road, Birmingham, West Midlands B17 7QH, United Kingdom. victorhu@doctors.org.uk
Zaidi
Farhan
F
Larkin
Genevieve
G
Muir
Gordon
G
Stanford
Miles
M
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D019072:Antibiotic Prophylaxis; D016470:Bacteremia / Q000209:etiology; D002442:Ceftazidime / Q000627:therapeutic use; D002443:Ceftriaxone / Q000627:therapeutic use; D002506:Cephalexin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D009877:Endophthalmitis / Q000188:drug therapy / Q000209:etiology*; D005260:Female; D005839:Gentamicins / Q000627:therapeutic use; D006695:Holmium; D006801:Humans; D017602:Lithotripsy, Laser / Q000009:adverse effects*; D008875:Middle Aged; D011552:Pseudomonas Infections / Q000188:drug therapy / Q000209:etiology*; D014514:Ureteral Calculi / Q000628:therapy; D014552:Urinary Tract Infections / Q000150:complications / Q000188:drug therapy; D014640:Vancomycin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D014640:Vancomycin; D002443:Ceftriaxone; D002442:Ceftazidime; D002506:Cephalexin; D006695:Holmium